Evidence map›Paper›PMID 36913101›Full record

ArticleBiotechnology letters2023

Identification of vitamin B

Darya Dudko, Sofia Milker, Dirk Holtmann, Markus Buchhaupt

Open access · hybridFull text read
In one paragraph

Article in Biotechnology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Darya DudkoMicrobial Biotechnology, DECHEMA Research Institute, Theodor-Heuss-Allee 25, 60486, Frankfurt am Main, Germany.
Sofia MilkerMicrobial Biotechnology, DECHEMA Research Institute, Theodor-Heuss-Allee 25, 60486, Frankfurt am Main, Germany.
Dirk HoltmannMicrobial Biotechnology, DECHEMA Research Institute, Theodor-Heuss-Allee 25, 60486, Frankfurt am Main, Germany.
Markus BuchhauptMicrobial Biotechnology, DECHEMA Research Institute, Theodor-Heuss-Allee 25, 60486, Frankfurt am Main, Germany. markus.buchhaupt@dechema.de.ORCID http://orcid.org/0000-0003-2720-5973
Society for Chemical Engineering and Biotechnology · DE

Funding

Hessisches Ministerium für Wissenschaft und Kunst AROMAplus
6 · The paper itself

Abstract

objectivesThe objective of the study was to develop a strategy for the identification of new vitamin B

resultsSearching for homologues of the bluB/cobT2 fusion gene known to be responsible for the production of the active vitamin B

conclusionsThe proposed strategy enabled identification of Terrabacter sp. DSM102553, whose relatively high yields obtained in the minimal medium open new perspectives for the possible application of the strain for biotechnological vitamin B

Indexed as

Tandem Mass SpectrometryVitamin B 12BacteriaChromatography, LiquidVitaminsVitamin B 12VitaminsBluB/CobT2CobalaminLC–MS/MSMethod validationPseudovitamin B12Terrabacter sp.Vitamin B12

Identifiers

PMID36913101
PMCPMC10038948
OpenAlexW4324020416

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read38
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.